Examination of Glutamate and mGluR5 in Psychiatric Disorders

What is the purpose of this trial?

This research study is designed to look at the involvement of the glutamate system in depression. Each subject will undergo a screening appointment to determine study eligibility. Thereafter, the study will take 2 or 3 visits depending on schedule availability and will consist of one MRI scan, and PET scan. Subjects will also participate in cognitive testing. Depending on camera time, staff availability and subject schedule, total study participation may last 1-2 months.


Participation Guidelines

Ages: 18 - 65 years

Gender: Both


Yale University School of Medicine

Start Date: 08/23/2011

End Date: 08/22/2021

Last Updated: 12/12/2018

Study HIC#: 1101007933

Get Involved

For more information about this study, contact:
Nicole DellaGioia
+1 203-737-6884
nicole.dellagioia@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image